Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

50.20
+0.98001.99%
Pre-market: 49.90-0.3000-0.60%08:30 EDT
Volume:15.95M
Turnover:796.86M
Market Cap:102.16B
PE:18.80
High:50.35
Open:50.19
Low:49.15
Close:49.22
Loading ...

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)

TIPRANKS
·
25 Apr

Bristol-Myers Squibb Company (BMY): A Growing Dividend Stock with Low PE Ratio

Insider Monkey
·
25 Apr

Bristol-Myers Squibb Co : JP Morgan Cuts Target Price to $67 From $70

THOMSON REUTERS
·
25 Apr

Bristol-Myers Squibb’s Earnings Call: Strong Growth Amid Challenges

TIPRANKS
·
25 Apr

Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy. -- Barrons.com

Dow Jones
·
25 Apr

Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields. -- Barrons.com

Dow Jones
·
25 Apr

BUZZ-Cytokinetics rises as Bristol Myers flags 'steady growth' for rival drug

Reuters
·
25 Apr

JPMorgan Cuts Price Target on Bristol-Myers Squibb to $67 From $70

MT Newswires Live
·
25 Apr

Bristol-Myers Squibb (NYSE:BMY) Raises 2025 Revenue Guidance Following Strong Q1 Performance

Simply Wall St.
·
25 Apr

Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results

Benzinga
·
25 Apr

Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact

Benzinga
·
24 Apr

BMY Beats on Q1 Earnings and Sales, Raises 2025 Outlook

Zacks
·
24 Apr

BUZZ-U.S. STOCKS ON THE MOVE- PepsiCo, Procter & Gamble

Reuters
·
24 Apr

Bristol-Myers Squibb Co reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
24 Apr

Compared to Estimates, Bristol Myers (BMY) Q1 Earnings: A Look at Key Metrics

Zacks
·
24 Apr

Bristol Myers Squibb Raises Guidance, But Any Pharma-Sector Tariffs Could be a Drag -- Market Talk

Dow Jones
·
24 Apr

Bristol-Myers Squibb Q1 2025 Financial Results Announced

TIPRANKS
·
24 Apr

Bristol-Myers Squibb Swings to Q1 Earnings, Reports Lower Revenue; Updates Full-Year 2025 Guidance

MT Newswires Live
·
24 Apr

Bristol Myers Shares up 1.4% Premarket After Co Raises FY REV Forecast

THOMSON REUTERS
·
24 Apr

Bristol Myers Posts Better-Than-Expected Quarterly Revenue on Strong Cancer Drug Sales

Reuters
·
24 Apr